KAVIN HANZIK: Open Payments
NPI 1952460750 · WEBSTER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,459 in 98 payments from 36 companies in 2025. Trend: 2023 $1,475 · 2024 $1,436 · 2025 $2,459
Food & beverage: $2,264Education: $195
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $339 |
| Astellas Pharma US Inc | 5 | $226 |
| Merck Sharp & Dohme LLC | 8 | $213 |
| PFIZER INC. | 8 | $183 |
| ABBVIE INC. | 6 | $156 |
| E.R. Squibb & Sons, L.L.C. | 6 | $146 |
| Janssen Biotech, Inc. | 6 | $142 |
| Incyte Corporation | 5 | $90 |
| AstraZeneca Pharmaceuticals LP | 3 | $79 |
| Gilead Sciences, Inc. | 3 | $76 |
Products named: KEYTRUDA, KISQALI, Fabhalta, EPKINLY, OPDIVO, Trodelvy, MONOFERRIC, CARVYKTI.
Industry payments across TX — which companies pay providers there.
